Expensive deal valuations to hit Torrent Pharma's near-term earnings
Sales trajectory in domestic formulations and resolution of regulatory issues are other triggers28-09-2022
28-09-2022
TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the Company by Designated Persons stands closed from 1st October, 2022 and will be re-opened 48 hours after the submission of the Financial Results for the Quarter ended 30th September, 2022 to the Stock Exchanges.28-09-2022
Torrent Pharma Management Call: Acquisition of Curatio Healthcare
Conference Call with Torrent Pharmaceuticals Management and Analysts on its acquisition of Curatio Healthcare. Listen to the full transcript.27-09-2022
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation to analysts on acquisition of Curatio Health Care (I) Private Limited27-09-2022
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Conference call with investors / analyst27-09-2022
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Torrent Pharma to acquire Curatio Healthcare27-09-2022
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Acquisition
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')27-09-2022
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201517-09-2022
1 lakh skyrocketed 1000 times to 17 Cr after 3 bonus shares: Buy the stock
With a market capitalization of 51,456.63 Crore, Torrent Pharmaceuticals Ltd. is a large cap company in the pharmaceutical industry09-09-2022
TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Torrent Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here09-09-2022